A trial looking at divarasib, sotorasib or adagrasib for non small cell lung cancer that has spread (Krascendo 1)

This trial is looking at a new drug called divarasib for non small cell lung cancer that has got worse after treatment. It is comparing this to a drug called sotorasib and another drug called adagrasib.

The trial is for people whose cancer:

• has a KRAS G12C gene change (mutation) and

• has grown into surrounding tissues or to another part of the body

You pronounce divarasib as di-va-ra-sib.

You pronounce sotorasib as so-tour-ah-sib.

You pronounce adagrasib as a-dah-gra-sib.